Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 36.24% is 29% above its 5-year average of 28.07%, near the high end of its 5-year range (15.13%–44.86%).
3.67% above its 12-month average of 34.96%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 33.23%.
OPERATING MARGIN
36.24%
OPERATING MARGIN AVG TTM
34.96%
OPERATING MARGIN AVG 3Y
28.91%
OPERATING MARGIN AVG 5Y
28.07%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+3.67%
CURRENT VS 3Y AVG
+25.34%
CURRENT VS 5Y AVG
+29.10%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 836 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Sotera Health Company
Market Cap
$5.24B
Operating Margin
36.24%
TTM Avg
34.96%
3Y Avg
28.91%
5Y Avg
28.07%
Market Cap
$5.24B
Operating Margin
-16191.40%
TTM Avg
-8762.23%
3Y Avg
-42994.83%
5Y Avg
-36872.33%
Market Cap
$5.31B
Operating Margin
49.49%
TTM Avg
6.00%
3Y Avg
-24.72%
5Y Avg
-46.97%
Market Cap
$5.17B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-174.05%
Market Cap
$5.16B
Operating Margin
-6.84%
TTM Avg
-75.84%
3Y Avg
-177.77%
5Y Avg
-158.53%
Market Cap
$5.06B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-101.20%
5Y Avg
-276.55%
Market Cap
$5.06B
Operating Margin
12.75%
TTM Avg
11.82%
3Y Avg
10.28%
5Y Avg
7.77%
Market Cap
$5.49B
Operating Margin
0.53%
TTM Avg
-2.93%
3Y Avg
-2.93%
5Y Avg
-2.93%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sotera Health Company (SHC) | $5.24B | 36.24% | 34.96% | 28.91% | 28.07% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.24B | -16191.40% | -8762.23% | -42994.83% | -36872.33% |
| Doximity, Inc. (DOCS)vs › | $5.27B | 29.60% | 36.63% | 34.40% | 32.73% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.31B | 49.49% | 6.00% | -24.72% | -46.97% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.17B | 0.00% | 0.00% | 0.00% | -174.05% |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.16B | -6.84% | -75.84% | -177.77% | -158.53% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.06B | 0.00% | 0.00% | -101.20% | -276.55% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.06B | 12.75% | 11.82% | 10.28% | 7.77% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.49B | 0.53% | -2.93% | -2.93% | -2.93% |
| RadNet, Inc. (RDNT)vs › | $5.52B | 4.00% | 5.08% | 4.88% | 4.85% |
Gross Margin
54.7%
Operating Margin
36.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 33.23% |
| 2026-03-31 | 30.94% |
| 2025-12-31 | 44.86% |
| 2025-09-30 | 35.71% |
| 2025-06-30 | 30.04% |
| 2025-03-31 | 22.41% |
| 2024-12-31 | 30.03% |
| 2024-09-30 | 28.20% |
| 2024-06-30 | 27.77% |
| 2024-03-31 | 21.43% |
| 2023-12-31 | 33.53% |
| 2023-09-30 | 28.92% |
| 2023-06-30 | 24.76% |
| 2023-03-31 | 15.13% |
| 2022-12-31 | 23.92% |
| 2022-09-30 | 25.41% |
| 2022-06-30 | 26.81% |
| 2022-03-31 | 22.59% |
| 2021-12-31 | 27.53% |
| 2021-09-30 | 29.04% |
| 2021-06-30 | 31.07% |
| 2021-03-31 | 21.85% |
| 2020-12-31 | 24.16% |
| 2020-09-30 | 23.51% |
| 2020-06-30 | 28.98% |
| 2020-03-31 | 23.84% |
| 2019-12-31 | 23.50% |
| 2019-09-30 | 18.21% |
| 2019-06-30 | 26.89% |
| 2019-03-31 | 26.89% |
